Kathleen Lamborn, PhD

Title(s)Professor Emeritus, Neurological Surgery
SchoolSchool of Medicine
Address1001 Potrero Ave, #01
San Francisco CA 94110
Phone415-353-2863
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Research 
    Collapse Research Activities and Funding
    Brain Tumor SPORE Grant
    NIH P50CA097257Sep 20, 2002 - Aug 31, 2023
    Role: Co-Investigator
    Cancer Center Support Grant
    NIH P30CA082103Aug 5, 1999 - May 31, 2023
    Role: Co-Investigator
    Translational Multimodality " Antibody" Therapy
    NIH P01CA047829Jul 15, 1988 - Mar 31, 2009
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa124. Chen H, Kuhn J, Lamborn KR, Abrey LE, DeAngelis LM, Lieberman F, Robins HI, Chang SM, Yung WKA, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados MD, Cloughesy TF, Wen PY, Gilbert MR. PMID: 33235994; PMCID: PMC7668489.
      View in: PubMed   Mentions: 7  
    2. Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02. Neuro Oncol. 2014 Apr; 16(4):567-78. Wen PY, Chang SM, Lamborn KR, Kuhn JG, Norden AD, Cloughesy TF, Robins HI, Lieberman FS, Gilbert MR, Mehta MP, Drappatz J, Groves MD, Santagata S, Ligon AH, Yung WK, Wright JJ, Dancey J, Aldape KD, Prados MD, Ligon KL. PMID: 24470557; PMCID: PMC3956354.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCTClinical Trials
    3. Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol. 2013 Sep; 14(10):e396-406. Lin NU, Lee EQ, Aoyama H, Barani IJ, Baumert BG, Brown PD, Camidge DR, Chang SM, Dancey J, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Lamborn KR, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Wen PY, Response Assessment in Neuro-Oncology (RANO) group. PMID: 23993384.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    4. Visual field defects after radiosurgery for mesial temporal lobe epilepsy. Epilepsia. 2013 Aug; 54(8):1376-80. Hensley-Judge H, Quigg M, Barbaro NM, Newman SA, Ward MM, Chang EF, Broshek DK, Lamborn KR, Laxer KD, Garcia P, Heck CN, Kondziolka D, Beach R, Salanova V, Goodman R. PMID: 23663063; PMCID: PMC6036909.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    5. Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging. Neuro Oncol. 2013 May; 15(5):607-17. Li Y, Lupo JM, Parvataneni R, Lamborn KR, Cha S, Chang SM, Nelson SJ. PMID: 23393206; PMCID: PMC3635514.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    6. Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02. Neuro Oncol. 2012 Dec; 14(12):1511-8. Lee EQ, Kuhn J, Lamborn KR, Abrey L, DeAngelis LM, Lieberman F, Robins HI, Chang SM, Yung WK, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados MD, Cloughesy TF, Gilbert MR, Wen PY. PMID: 23099651; PMCID: PMC3499017.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCTClinical Trials
    7. Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03. Clin Cancer Res. 2012 Nov 01; 18(21):6032-9. Lee EQ, Puduvalli VK, Reid JM, Kuhn JG, Lamborn KR, Cloughesy TF, Chang SM, Drappatz J, Yung WK, Gilbert MR, Robins HI, Lieberman FS, Lassman AB, McGovern RM, Xu J, Desideri S, Ye X, Ames MM, Espinoza-Delgado I, Prados MD, Wen PY. PMID: 22923449; PMCID: PMC3947570.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    8. Phase 2 trial design in neuro-oncology revisited: a report from the RANO group. Lancet Oncol. 2012 May; 13(5):e196-204. Galanis E, Wu W, Cloughesy T, Lamborn K, Mann B, Wen PY, Reardon DA, Wick W, Macdonald D, Armstrong TS, Weller M, Vogelbaum M, Colman H, Sargent DJ, van den Bent MJ, Gilbert M, Chang S. PMID: 22554547.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    9. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov. 2012 May; 2(5):458-71. Vivanco I, Robins HI, Rohle D, Campos C, Grommes C, Nghiemphu PL, Kubek S, Oldrini B, Chheda MG, Yannuzzi N, Tao H, Zhu S, Iwanami A, Kuga D, Dang J, Pedraza A, Brennan CW, Heguy A, Liau LM, Lieberman F, Yung WK, Gilbert MR, Reardon DA, Drappatz J, Wen PY, Lamborn KR, Chang SM, Prados MD, Fine HA, Horvath S, Wu N, Lassman AB, DeAngelis LM, Yong WH, Kuhn JG, Mischel PS, Mehta MP, Cloughesy TF, Mellinghoff IK. PMID: 22588883; PMCID: PMC3354723.
      View in: PubMed   Mentions: 196     Fields:    Translation:HumansAnimalsCells
    10. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neurooncol. 2012 May; 108(1):133-9. Schoenfeld A, Pekmezci M, Barnes MJ, Tihan T, Gupta N, Lamborn KR, Banerjee A, Mueller S, Chang S, Berger MS, Haas-Kogan D. PMID: 22350375; PMCID: PMC3879154.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    11. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery. 2012 Feb; 70(2):361-70. Clark AJ, Lamborn KR, Butowski NA, Chang SM, Prados MD, Clarke JL, McDermott MW, Parsa AT, Berger MS, Aghi MK. PMID: 21841523.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    12. Spatial characteristics of newly diagnosed grade 3 glioma assessed by magnetic resonance metabolic and diffusion tensor imaging. Transl Oncol. 2012 Feb; 5(1):10-8. Ozturk-Isik E, Pirzkall A, Lamborn KR, Cha S, Chang SM, Nelson SJ. PMID: 22348171; PMCID: PMC3281410.
      View in: PubMed   Mentions: 6  
    13. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):303-9. Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW. PMID: 22079723.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    14. Suprasellar Rathke cleft cysts: clinical presentation and treatment outcomes. Neurosurgery. 2011 Nov; 69(5):1058-68; discussion 1068-7. Potts MB, Jahangiri A, Lamborn KR, Blevins LS, Kunwar S, Aghi MK. PMID: 21673610.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    15. Conditional probability of survival in patients with newly diagnosed glioblastoma. J Clin Oncol. 2011 Nov 01; 29(31):4175-80. Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M. PMID: 21969507; PMCID: PMC3208537.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    16. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Neuro Oncol. 2011 Dec; 13(12):1331-8. Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, Vandenberg S, Parvataneni R, Nicole A, Sneed PK, Clarke J, Hsieh E, Costa BM, Reis RM, Hristova-Kazmierski M, Nicol SJ, Thornton DE, Prados MD. PMID: 21896554; PMCID: PMC3223090.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCellsCTClinical Trials
    17. Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro Oncol. 2011 Oct; 13(10):1118-24. Clarke JL, Ennis MM, Yung WK, Chang SM, Wen PY, Cloughesy TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Lamborn KR, Prados MD, North American Brain Tumor Consortium. PMID: 21813511; PMCID: PMC3177665.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    18. Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery. J Neurooncol. 2012 Jan; 106(1):147-53. Gilbert MR, Kuhn J, Lamborn KR, Lieberman F, Wen PY, Mehta M, Cloughesy T, Lassman AB, Deangelis LM, Chang S, Prados M. PMID: 21739168; PMCID: PMC4351869.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCTClinical Trials
    19. Factors associated with delay to pituitary adenoma diagnosis in patients with visual loss. J Neurosurg. 2012 Feb; 116(2):283-9. Jahangiri A, Lamborn KR, Blevins L, Kunwar S, Aghi MK. PMID: 21740118.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    20. Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol. 2011 Jul 01; 29(19):2689-95. de Groot JF, Lamborn KR, Chang SM, Gilbert MR, Cloughesy TF, Aldape K, Yao J, Jackson EF, Lieberman F, Robins HI, Mehta MP, Lassman AB, Deangelis LM, Yung WK, Chen A, Prados MD, Wen PY. PMID: 21606416; PMCID: PMC3139373.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCTClinical Trials
    21. Neuropsychological outcomes after Gamma Knife radiosurgery for mesial temporal lobe epilepsy: a prospective multicenter study. Epilepsia. 2011 May; 52(5):909-16. Quigg M, Broshek DK, Barbaro NM, Ward MM, Laxer KD, Yan G, Lamborn K, Radiosurgery Epilepsy Study Group. PMID: 21426323; PMCID: PMC3519361.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    22. A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03. Neuro Oncol. 2011 May; 13(5):509-16. Iwamoto FM, Lamborn KR, Kuhn JG, Wen PY, Yung WK, Gilbert MR, Chang SM, Lieberman FS, Prados MD, Fine HA. PMID: 21377994; PMCID: PMC3093337.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    23. Identifying the needs of brain tumor patients and their caregivers. J Neurooncol. 2011 Sep; 104(3):737-44. Parvataneni R, Polley MY, Freeman T, Lamborn K, Prados M, Butowski N, Liu R, Clarke J, Page M, Rabbitt J, Fedoroff A, Clow E, Hsieh E, Kivett V, Deboer R, Chang S. PMID: 21311950; PMCID: PMC3170122.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    24. Clinical trial end points for high-grade glioma: the evolving landscape. Neuro Oncol. 2011 Mar; 13(3):353-61. Reardon DA, Galanis E, DeGroot JF, Cloughesy TF, Wefel JS, Lamborn KR, Lassman AB, Gilbert MR, Sampson JH, Wick W, Chamberlain MC, Macdonald DR, Mehta MP, Vogelbaum MA, Chang SM, Van den Bent MJ, Wen PY. PMID: 21310734; PMCID: PMC3064608.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    25. A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1422-7. Nghiemphu PL, Wen PY, Lamborn KR, Drappatz J, Robins HI, Fink K, Malkin MG, Lieberman FS, DeAngelis LM, Torres-Trejo A, Chang SM, Abrey L, Fine HA, Demopoulos A, Lassman AB, Kesari S, Mehta MP, Prados MD, Cloughesy TF, North American Brain Tumor Consortium. PMID: 20934264; PMCID: PMC3020272.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    26. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010 Apr 10; 28(11):1963-72. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. PMID: 20231676.
      View in: PubMed   Mentions: 1855     Fields:    Translation:Humans
    27. Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update. J Neurooncol. 2010 Oct; 100(1):121-7. Mishra KK, Squire S, Lamborn K, Banerjee A, Gupta N, Wara WM, Prados MD, Berger MS, Haas-Kogan DA. PMID: 20221671; PMCID: PMC2951507.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    28. Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02). Neuro Oncol. 2010 Aug; 12(8):855-61. Iwamoto FM, Lamborn KR, Robins HI, Mehta MP, Chang SM, Butowski NA, Deangelis LM, Abrey LE, Zhang WT, Prados MD, Fine HA. PMID: 20200024; PMCID: PMC2940686.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCTClinical Trials
    29. Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study. Neuro Oncol. 2010 Jun; 12(6):608-13. Butowski N, Chang SM, Lamborn KR, Polley MY, Parvataneni R, Hristova-Kazmierski M, Musib L, Nicol SJ, Thornton DE, Prados MD. PMID: 20156802; PMCID: PMC2940647.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    30. Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma. Neuro Oncol. 2010 Feb; 12(2):164-72. Wu W, Lamborn KR, Buckner JC, Novotny PJ, Chang SM, O'Fallon JR, Jaeckle KA, Prados MD. PMID: 20150383; PMCID: PMC2940570.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    31. Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide. Neuro Oncol. 2010 Mar; 12(3):274-82. Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M. PMID: 20167815; PMCID: PMC2940590.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    32. A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas. Neuro Oncol. 2010 Jan; 12(1):87-94. Raizer JJ, Abrey LE, Lassman AB, Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Aldape KD, Wen PY, Fine HA, Mehta M, Deangelis LM, Lieberman F, Cloughesy TF, Robins HI, Dancey J, Prados MD, North American Brain Tumor Consortium. PMID: 20150371; PMCID: PMC2940559.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    33. A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro Oncol. 2010 Jan; 12(1):95-103. Raizer JJ, Abrey LE, Lassman AB, Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Aldape KA, Wen PY, Fine HA, Mehta M, Deangelis LM, Lieberman F, Cloughesy TF, Robins HI, Dancey J, Prados MD, North American Brain Tumor Consortium. PMID: 20150372; PMCID: PMC2940554.
      View in: PubMed   Mentions: 138     Fields:    Translation:HumansCTClinical Trials
    34. Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro Oncol. 2009 Dec; 11(6):842-52. Pirzkall A, McGue C, Saraswathy S, Cha S, Liu R, Vandenberg S, Lamborn KR, Berger MS, Chang SM, Nelson SJ. PMID: 19229057; PMCID: PMC2802404.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    35. Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro Oncol. 2009 Dec; 11(6):853-60. Wen PY, Yung WK, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE, Fine HA, Chang SM, Robins HI, Fink K, Deangelis LM, Mehta M, Di Tomaso E, Drappatz J, Kesari S, Ligon KL, Aldape K, Jain RK, Stiles CD, Egorin MJ, Prados MD. PMID: 19293394; PMCID: PMC2802405.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCTClinical Trials
    36. Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging. Transl Oncol. 2009 Dec; 2(4):271-80. Bian W, Khayal IS, Lupo JM, McGue C, Vandenberg S, Lamborn KR, Chang SM, Cha S, Nelson SJ. PMID: 19956389; PMCID: PMC2781083.
      View in: PubMed   Mentions: 20  
    37. Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival. J Neurooncol. 2010 Mar; 97(1):33-40. McBride SM, Perez DA, Polley MY, Vandenberg SR, Smith JS, Zheng S, Lamborn KR, Wiencke JK, Chang SM, Prados MD, Berger MS, Stokoe D, Haas-Kogan DA. PMID: 19705067; PMCID: PMC2814032.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    38. Radiation-induced reductions in neurogenesis are ameliorated in mice deficient in CuZnSOD or MnSOD. Free Radic Biol Med. 2009 Nov 15; 47(10):1459-67. Fishman K, Baure J, Zou Y, Huang TT, Andres-Mach M, Rola R, Suarez T, Acharya M, Limoli CL, Lamborn KR, Fike JR. PMID: 19703553; PMCID: PMC2767469.
      View in: PubMed   Mentions: 36     Fields:    Translation:AnimalsCells
    39. Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. J Neurooncol. 2010 Jan; 96(2):211-7. Norden AD, Raizer JJ, Abrey LE, Lamborn KR, Lassman AB, Chang SM, Yung WK, Gilbert MR, Fine HA, Mehta M, Deangelis LM, Cloughesy TF, Robins HI, Aldape K, Dancey J, Prados MD, Lieberman F, Wen PY. PMID: 19562255; PMCID: PMC3786190.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCTClinical Trials
    40. Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. J Neurooncol. 2009 May; 93(1):151-6. Cage TA, Lamborn KR, Ware ML, Frankfurt A, Chakalian L, Berger MS, McDermott MW. PMID: 19430892.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    41. Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas. NMR Biomed. 2009 May; 22(4):449-55. Khayal IS, McKnight TR, McGue C, Vandenberg S, Lamborn KR, Chang SM, Cha S, Nelson SJ. PMID: 19125391; PMCID: PMC3772178.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    42. A multicenter, prospective pilot study of gamma knife radiosurgery for mesial temporal lobe epilepsy: seizure response, adverse events, and verbal memory. Ann Neurol. 2009 Feb; 65(2):167-75. Barbaro NM, Quigg M, Broshek DK, Ward MM, Lamborn KR, Laxer KD, Larson DA, Dillon W, Verhey L, Garcia P, Steiner L, Heck C, Kondziolka D, Beach R, Olivero W, Witt TC, Salanova V, Goodman R. PMID: 19243009.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    43. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol. 2009 Jul; 93(3):349-54. Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, Chang S, Lamborn KR, McDermott MW. PMID: 19169651; PMCID: PMC2687520.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    44. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol. 2009 Feb 01; 27(4):579-84. Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, Kabuubi P, Ayers-Ringler J, Rabbitt J, Page M, Fedoroff A, Sneed PK, Berger MS, McDermott MW, Parsa AT, Vandenberg S, James CD, Lamborn KR, Stokoe D, Haas-Kogan DA. PMID: 19075262; PMCID: PMC2645859.
      View in: PubMed   Mentions: 169     Fields:    Translation:HumansCTClinical Trials
    45. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site. J Neurosurg. 2008 Dec; 109 Suppl:77-86. Golden DW, Lamborn KR, McDermott MW, Kunwar S, Wara WM, Nakamura JL, Sneed PK. PMID: 19123892.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    46. Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM. J Neurooncol. 2009 Feb; 91(3):337-51. Crawford FW, Khayal IS, McGue C, Saraswathy S, Pirzkall A, Cha S, Lamborn KR, Chang SM, Berger MS, Nelson SJ. PMID: 19009235; PMCID: PMC3022444.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    47. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg. 2008 Nov; 109(5):817-24. Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM. PMID: 18976070.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    48. A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas. J Neurooncol. 2009 Jan; 91(2):183-9. Butowski N, Lamborn KR, Lee BL, Prados MD, Cloughesy T, DeAngelis LM, Abrey L, Fink K, Lieberman F, Mehta M, Ian Robins H, Junck L, Salazar AM, Chang SM. PMID: 18850068; PMCID: PMC3104130.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    49. Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. J Neurooncol. 2009 Jan; 91(1):69-81. Saraswathy S, Crawford FW, Lamborn KR, Pirzkall A, Chang S, Cha S, Nelson SJ. PMID: 18810326; PMCID: PMC3022437.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    50. A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05). J Neurooncol. 2009 Jan; 91(2):175-82. Butowski N, Chang SM, Junck L, DeAngelis LM, Abrey L, Fink K, Cloughesy T, Lamborn KR, Salazar AM, Prados MD. PMID: 18797818; PMCID: PMC4779120.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    51. Signal transduction molecules in gliomas of all grades. J Neurooncol. 2009 Jan; 91(1):19-26. Ermoian RP, Kaprealian T, Lamborn KR, Yang X, Jelluma N, Arvold ND, Zeidman R, Berger MS, Stokoe D, Haas-Kogan DA. PMID: 18759130; PMCID: PMC2879130.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    52. In reference to lamborn et Al. (Neuro-oncology. 2008;10:162-170). Neuro Oncol. 2008 Dec; 10(6):1171-2. Meyers CA, Lamborn KR, Prados MD. PMID: 18725461; PMCID: PMC2719004.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. Quality of life in low-grade glioma patients receiving temozolomide. Neuro Oncol. 2009 Feb; 11(1):59-68. Liu R, Solheim K, Polley MY, Lamborn KR, Page M, Fedoroff A, Rabbitt J, Butowski N, Prados M, Chang SM. PMID: 18713953; PMCID: PMC2718960.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    54. Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium. Neuro Oncol. 2008 Aug; 10(4):631-42. Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Wen PY, Fine HA, Mehta MP, DeAngelis LM, Lieberman FS, Cloughesy TF, Robins HI, Abrey LE, Prados MD, North American Brain Tumor Consortium. PMID: 18559968; PMCID: PMC2666238.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    55. Hippocampal neurogenesis and neuroinflammation after cranial irradiation with (56)Fe particles. Radiat Res. 2008 Jun; 169(6):626-32. Rola R, Fishman K, Baure J, Rosi S, Lamborn KR, Obenaus A, Nelson GA, Fike JR. PMID: 18494546; PMCID: PMC2583781.
      View in: PubMed   Mentions: 54     Fields:    Translation:AnimalsCells
    56. Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1319-23. McBride SM, Daganzo SM, Banerjee A, Gupta N, Lamborn KR, Prados MD, Berger MS, Wara WM, Haas-Kogan DA. PMID: 18485615.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    57. Relationship between choline and apparent diffusion coefficient in patients with gliomas. J Magn Reson Imaging. 2008 Apr; 27(4):718-25. Khayal IS, Crawford FW, Saraswathy S, Lamborn KR, Chang SM, Cha S, McKnight TR, Nelson SJ. PMID: 18383265; PMCID: PMC3030277.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    58. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J Neurosurg. 2008 Apr; 108(4):736-45. Chang EF, Zada G, Kim S, Lamborn KR, Quinones-Hinojosa A, Tyrrell JB, Wilson CB, Kunwar S. PMID: 18377253.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    59. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008 Mar 10; 26(8):1338-45. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS. PMID: 18323558.
      View in: PubMed   Mentions: 398     Fields:    Translation:Humans
    60. Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro Oncol. 2008 Apr; 10(2):162-70. Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, DeAngelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Hibberts J, Peterson PM, Prados MD, North American Brain Tumor Consortium. PMID: 18356283; PMCID: PMC2613818.
      View in: PubMed   Mentions: 225     Fields:    Translation:Humans
    61. New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163. Neuro Oncol. 2008 Apr; 10(2):112-20. Hashizume R, Ozawa T, Gryaznov SM, Bollen AW, Lamborn KR, Frey WH, Deen DF. PMID: 18287341; PMCID: PMC2613813.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    62. Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome. Neurosurgery. 2008 Feb; 62 Suppl 2:884-94. Papavassiliou E, Rau G, Heath S, Abosch A, Barbaro NM, Larson PS, Lamborn K, Starr PA. PMID: 18596419.
      View in: PubMed   Mentions: 15     Fields:    
    63. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008 Feb; 108(2):227-35. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, Berger MS. PMID: 18240916.
      View in: PubMed   Mentions: 162     Fields:    Translation:Humans
    64. Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma. Clin Cancer Res. 2007 Dec 15; 13(24):7401-6. Kuhn JG, Chang SM, Wen PY, Cloughesy TF, Greenberg H, Schiff D, Conrad C, Fink KL, Robins HI, Mehta M, DeAngelis L, Raizer J, Hess K, Lamborn KR, Dancey J, Prados MD, North American Brain Tumor Consortium and the National Cancer Institute. PMID: 18094423; PMCID: PMC4918812.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    65. Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study. Clin Cancer Res. 2007 Dec 01; 13(23):7133-8. Loghin ME, Prados MD, Wen P, Junck L, Lieberman F, Fine H, Fink KL, Metha M, Kuhn J, Lamborn K, Chang SM, Cloughesy T, DeAngelis LM, Robins IH, Aldape KD, Yung WK. PMID: 18056194; PMCID: PMC4802002.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    66. Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma. Cancer Biother Radiopharm. 2007 Aug; 22(4):521-30. Schillaci O, DeNardo GL, DeNardo SJ, Goldstein DS, Kroger LA, O'Donnell RT, Lamborn KR. PMID: 17803447.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    67. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol. 2007 Jun-Jul; 28(6):1078-84. Cha S, Lupo JM, Chen MH, Lamborn KR, McDermott MW, Berger MS, Nelson SJ, Dillon WP. PMID: 17569962; PMCID: PMC8134129.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    68. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2007 Nov 01; 69(3):825-30. Chen AM, Chang S, Pouliot J, Sneed PK, Prados MD, Lamborn KR, Malec MK, McDermott MW, Berger MS, Larson DA. PMID: 17512132.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    69. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol. 2007 Jul; 9(3):271-9. Wiencke JK, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamgüney T, Baumber R, Parsons R, Lamborn KR, Berger MS, Wrensch MR, Haas-Kogan DA, Stokoe D. PMID: 17504928; PMCID: PMC1907411.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    70. Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme. J Neurooncol. 2007 Oct; 85(1):87-94. Butowski N, Lamborn KR, Berger MS, Prados MD, Chang SM. PMID: 17457513.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro. Int J Radiat Oncol Biol Phys. 2007 Apr 01; 67(5):1538-47. Chen JK, Hu LJ, Wang D, Lamborn KR, Deen DF. PMID: 17394949.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    72. Treatment for posterior fossa dissemination of primary supratentorial glioma. J Neurosurg. 2007 Apr; 106(4):567-74. Smith JS, Parney IF, Lamborn KR, McDermott MW, Sneed PK, Chang SM. PMID: 17432705.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    73. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg. 2007 Apr; 106(4):660-6. McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP, Bollen A, Nelson SJ. PMID: 17432719.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    74. In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas. Neuro Oncol. 2007 Apr; 9(2):82-8. Entin-Meer M, Yang X, VandenBerg SR, Lamborn KR, Nudelman A, Rephaeli A, Haas-Kogan DA. PMID: 17347490; PMCID: PMC1871664.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    75. Synthesis and comparative toxicology of a series of polyhedral borane anion-substituted tetraphenyl porphyrins. J Med Chem. 2007 Feb 22; 50(4):820-7. Koo MS, Ozawa T, Santos RA, Lamborn KR, Bollen AW, Deen DF, Kahl SB. PMID: 17253677.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    76. Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res. 2007 Jan 01; 13(1):68-75. Yoo H, Baia GS, Smith JS, McDermott MW, Bollen AW, Vandenberg SR, Lamborn KR, Lal A. PMID: 17200340.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    77. A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. J Neurooncol. 2007 Feb; 81(3):271-7. Groves MD, Puduvalli VK, Chang SM, Conrad CA, Gilbert MR, Tremont-Lukats IW, Liu TJ, Peterson P, Schiff D, Cloughesy TF, Wen PY, Greenberg H, Abrey LE, DeAngelis LM, Hess KR, Lamborn KR, Prados MD, Yung WK. PMID: 17031561.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    78. Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures. Int J Radiat Oncol Biol Phys. 2006 Sep 01; 66(1):263-70. Ozawa T, Faddegon BA, Hu LJ, Bollen AW, Lamborn KR, Deen DF. PMID: 16904526.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    79. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res. 2006 Aug 15; 12(16):4899-907. Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, Hayes M, Letvak L, Egorin MJ, Capdeville R, Kaplan R, Murgo AJ, Stiles C, Prados MD. PMID: 16914578.
      View in: PubMed   Mentions: 154     Fields:    Translation:HumansCTClinical Trials
    80. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. J Clin Oncol. 2006 Aug 01; 24(22):3651-6. Cloughesy TF, Wen PY, Robins HI, Chang SM, Groves MD, Fink KL, Junck L, Schiff D, Abrey L, Gilbert MR, Lieberman F, Kuhn J, DeAngelis LM, Mehta M, Raizer JJ, Yung WK, Aldape K, Wright J, Lamborn KR, Prados MD. PMID: 16877733.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    81. Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. J Neurosurg. 2006 Jul; 105(1):34-40. Keles GE, Chang EF, Lamborn KR, Tihan T, Chang CJ, Chang SM, Berger MS. PMID: 16871879.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    82. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res. 2006 Apr 15; 66(8):4531-41. Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, McMillan A, Kelsey KT, Aldape K, Lamborn KR, Parsa AT, Sison JD, Prados MD. PMID: 16618782.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    83. A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro Oncol. 2006 Apr; 8(2):189-93. Prados MD, Lamborn K, Yung WK, Jaeckle K, Robins HI, Mehta M, Fine HA, Wen PY, Cloughesy T, Chang S, Nicholas MK, Schiff D, Greenberg H, Junck L, Fink K, Hess K, Kuhn J, North American Brain Tumor Consortium. PMID: 16533878; PMCID: PMC1871932.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCTClinical Trials
    84. Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions? Hum Pathol. 2006 Mar; 37(3):272-82. Tihan T, Barletta J, Parney I, Lamborn K, Sneed PK, Chang S. PMID: 16613322.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansPHPublic Health
    85. The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas. Neuro Oncol. 2006 Apr; 8(2):166-74. Mishra KK, Puri DR, Missett BT, Lamborn KR, Prados MD, Berger MS, Banerjee A, Gupta N, Wara WM, Haas-Kogan DA. PMID: 16495375; PMCID: PMC1871938.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    86. Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies. Cancer Immunol Immunother. 2006 Dec; 55(12):1451-8. Azinovic I, DeNardo GL, Lamborn KR, Mirick G, Goldstein D, Bradt BM, DeNardo SJ. PMID: 16496145; PMCID: PMC11030743.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCTClinical Trials
    87. Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro Oncol. 2006 Jan; 8(1):67-78. Prados MD, Lamborn KR, Chang S, Burton E, Butowski N, Malec M, Kapadia A, Rabbitt J, Page MS, Fedoroff A, Xie D, Kelley SK. PMID: 16443950; PMCID: PMC1871925.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCTClinical Trials
    88. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro Oncol. 2006 Jan; 8(1):12-26. Wrensch M, Rice T, Miike R, McMillan A, Lamborn KR, Aldape K, Prados MD. PMID: 16443944; PMCID: PMC1871921.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    89. Chromosome transfer experiments link regions on chromosome 7 to radiation resistance in human glioblastoma multiforme. Genes Chromosomes Cancer. 2006 Jan; 45(1):20-30. Misra A, Pellarin M, Hu L, Kunwar S, Perhouse M, Lamborn KR, Deen DF, Feuerstein BG. PMID: 16130123.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    90. Implantation of different malignant human cell lines in an athymic mouse does not alter success and growth rates of either xenograft. Cancer Biother Radiopharm. 2005 Dec; 20(6):614-9. Miers L, DeNardo SJ, Lamborn K, DeNardo GL. PMID: 16398613.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    91. Bromophenol blue staining of tumors in a rat glioma model. Neurosurgery. 2005 Nov; 57(5):1041-7; discussion 1041-7. Ozawa T, Britz GW, Kinder DH, Spence AM, VandenBerg S, Lamborn KR, Deen DF, Berger MS. PMID: 16284574.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    92. Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clin Cancer Res. 2005 Nov 01; 11(21):7841-50. Lassman AB, Rossi MR, Raizer JJ, Razier JR, Abrey LE, Lieberman FS, Grefe CN, Lamborn K, Pao W, Shih AH, Kuhn JG, Wilson R, Nowak NJ, Cowell JK, DeAngelis LM, Wen P, Gilbert MR, Chang S, Yung WA, Prados M, Holland EC. PMID: 16278407.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCellsCTClinical Trials
    93. A design of phase II cancer trials using total and complete response endpoints. Stat Med. 2005 Oct 30; 24(20):3155-70. Lu Y, Jin H, Lamborn KR. PMID: 16189806.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    94. Biomarkers to predict response to epidermal growth factor receptor inhibitors. Cell Cycle. 2005 Oct; 4(10):1369-72. Haas-Kogan DA, Prados MD, Lamborn KR, Tihan T, Berger MS, Stokoe D. PMID: 16177570.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    95. Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers? Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7158s-7163s. Miers L, Lamborn K, Yuan A, Richman C, Natarajan A, DeNardo S, DeNardo G. PMID: 16203816.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    96. GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials. Neuro Oncol. 2005 Oct; 7(4):425-34. Chang SM, Reynolds SL, Butowski N, Lamborn KR, Buckner JC, Kaplan RS, Bigner DD. PMID: 16212807; PMCID: PMC1871726.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    97. Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. J Clin Oncol. 2005 Sep 20; 23(27):6647-56. Cloughesy TF, Kuhn J, Robins HI, Abrey L, Wen P, Fink K, Lieberman FS, Mehta M, Chang S, Yung A, DeAngelis L, Schiff D, Junck L, Groves M, Paquette S, Wright J, Lamborn K, Sebti SM, Prados M. PMID: 16170172.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    98. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model. Int J Radiat Oncol Biol Phys. 2005 Sep 01; 63(1):247-52. Ozawa T, Afzal J, Lamborn KR, Bollen AW, Bauer WF, Koo MS, Kahl SB, Deen DF. PMID: 16111595.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    99. High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody. Clin Cancer Res. 2005 Aug 15; 11(16):5920-7. Richman CM, Denardo SJ, O'Donnell RT, Yuan A, Shen S, Goldstein DS, Tuscano JM, Wun T, Chew HK, Lara PN, Kukis DL, Natarajan A, Meares CF, Lamborn KR, DeNardo GL. PMID: 16115934.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCTClinical Trials
    100. Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs. 2005 Aug; 23(4):357-61. Chang SM, Wen P, Cloughesy T, Greenberg H, Schiff D, Conrad C, Fink K, Robins HI, De Angelis L, Raizer J, Hess K, Aldape K, Lamborn KR, Kuhn J, Dancey J, Prados MD, North American Brain Tumor Consortium and the National Cancer Institute. PMID: 16012795.
      View in: PubMed   Mentions: 155     Fields:    Translation:HumansCTClinical Trials
    101. High failure rate in spinal ependymomas with long-term follow-up. Neuro Oncol. 2005 Jul; 7(3):254-9. Gomez DR, Missett BT, Wara WM, Lamborn KR, Prados MD, Chang S, Berger MS, Haas-Kogan DA. PMID: 16053700; PMCID: PMC1871913.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    102. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. J Natl Cancer Inst. 2005 Jun 15; 97(12):880-7. Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, Baumber R, Lamborn KR, Kapadia A, Malec M, Berger MS, Stokoe D. PMID: 15956649.
      View in: PubMed   Mentions: 179     Fields:    Translation:HumansCellsCTClinical Trials
    103. Hypoxia-induced BAX overexpression and radiation killing of hypoxic glioblastoma cells. Radiat Res. 2005 Jun; 163(6):644-53. Chen JK, Hu LJ, Wang J, Lamborn KR, Kong EL, Deen DF. PMID: 15913396.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    104. Changes in transcranial motor evoked potentials during intramedullary spinal cord tumor resection correlate with postoperative motor function. Neurosurgery. 2005 May; 56(5):982-93; discussion 982-93. Quiñones-Hinojosa A, Lyon R, Zada G, Lamborn KR, Gupta N, Parsa AT, McDermott MW, Weinstein PR. PMID: 15854246.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    105. Functionality of hypoxia-induced BAX expression in a human glioblastoma xenograft model. Cancer Gene Ther. 2005 May; 12(5):449-55. Ozawa T, Hu JL, Hu LJ, Kong EL, Bollen AW, Lamborn KR, Deen DF. PMID: 15706354.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    106. Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma. Clin Cancer Res. 2005 Apr 15; 11(8):2907-18. Misra A, Pellarin M, Nigro J, Smirnov I, Moore D, Lamborn KR, Pinkel D, Albertson DG, Feuerstein BG. PMID: 15837741.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    107. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A. 2005 Apr 19; 102(16):5814-9. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, Israel MA. PMID: 15827123; PMCID: PMC556127.
      View in: PubMed   Mentions: 242     Fields:    Translation:HumansCells
    108. A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma. Int J Radiat Oncol Biol Phys. 2005 Apr 01; 61(5):1454-9. Butowski N, Prados MD, Lamborn KR, Larson DA, Sneed PK, Wara WM, Malec M, Rabbitt J, Page M, Chang SM. PMID: 15817350.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    109. Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg. 2005 Apr; 102(4):622-8. Parsa AT, Wachhorst S, Lamborn KR, Prados MD, McDermott MW, Berger MS, Chang SM. PMID: 15871503.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    110. Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy. Cancer Gene Ther. 2005 Mar; 12(3):276-83. Wang D, Ruan H, Hu L, Lamborn KR, Kong EL, Rehemtulla A, Deen DF. PMID: 15650767.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    111. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. J Clin Endocrinol Metab. 2004 Dec; 89(12):6348-57. Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB. PMID: 15579802.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    112. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2004 Oct 01; 60(2):353-7. Chang SM, Lamborn KR, Malec M, Larson D, Wara W, Sneed P, Rabbitt J, Page M, Nicholas MK, Prados MD. PMID: 15380566.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    113. In vivo evaluation of the boronated porphyrin TABP-1 in U-87 MG intracerebral human glioblastoma xenografts. Mol Pharm. 2004 Sep-Oct; 1(5):368-74. Ozawa T, Santos RA, Lamborn KR, Bauer WF, Koo MS, Kahl SB, Deen DF. PMID: 16026007.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    114. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004 Jul; 6(3):227-35. Lamborn KR, Chang SM, Prados MD. PMID: 15279715; PMCID: PMC1871999.
      View in: PubMed   Mentions: 218     Fields:    Translation:Humans
    115. Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts. Neuro Oncol. 2004 Jul; 6(3):218-26. Ozawa T, Gryaznov SM, Hu LJ, Pongracz K, Santos RA, Bollen AW, Lamborn KR, Deen DF. PMID: 15279714; PMCID: PMC1871998.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    116. Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome. Neurosurgery. 2004 May; 54(5):1120-29; discussion 1129-30. Papavassiliou E, Rau G, Heath S, Abosch A, Barbaro NM, Larson PS, Lamborn K, Starr PA. PMID: 15113466.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    117. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro Oncol. 2004 Apr; 6(2):119-26. Larson DA, Suplica JM, Chang SM, Lamborn KR, McDermott MW, Sneed PK, Prados MD, Wara WM, Nicholas MK, Berger MS. PMID: 15134626; PMCID: PMC1871978.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    118. Intraoperative subcortical stimulation mapping for hemispherical perirolandic gliomas located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients. J Neurosurg. 2004 Mar; 100(3):369-75. Keles GE, Lundin DA, Lamborn KR, Chang EF, Ojemann G, Berger MS. PMID: 15035270.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    119. Temozolomide in the treatment of recurrent malignant glioma. Cancer. 2004 Feb 01; 100(3):605-11. Chang SM, Theodosopoulos P, Lamborn K, Malec M, Rabbitt J, Page M, Prados MD. PMID: 14745879.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    120. Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. J Neurosurg. 2004 Jan; 100(1):41-6. Keles GE, Lamborn KR, Chang SM, Prados MD, Berger MS. PMID: 14743910.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    121. Incidence of venous thromboembolism in patients undergoing craniotomy and motor mapping for glioma without intraoperative mechanical prophylaxis to the contralateral leg. J Neurosurg. 2003 Oct; 99(4):680-4. Auguste KI, Quinones-Hinojosa A, Gadkary C, Zada G, Lamborn KR, Berger MS. PMID: 14567603.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    122. Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3865S-72S. DeNardo GL, DeNardo SJ, Peterson JJ, Miers LA, Lam KS, Hartmann-Siantar C, Lamborn KR. PMID: 14506184.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    123. Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3938S-44S. DeNardo SJ, DeNardo GL, Yuan A, Richman CM, O'Donnell RT, Lara PN, Kukis DL, Natarajan A, Lamborn KR, Jacobs F, Siantar CL. PMID: 14506192.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    124. Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3854S-64S. DeNardo SJ, Yao Z, Lam KS, Song A, Burke PA, Mirick GR, Lamborn KR, O'Donnell RT, DeNardo GL. PMID: 14506183.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    125. Coregistration accuracy and detection of brain shift using intraoperative sononavigation during resection of hemispheric tumors. Neurosurgery. 2003 Sep; 53(3):556-62; discussion 562-4. Keles GE, Lamborn KR, Berger MS. PMID: 12943572.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    126. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3845S-53S. Winthrop MD, DeNardo SJ, Albrecht H, Mirick GR, Kroger LA, Lamborn KR, Venclovas C, Colvin ME, Burke PA, DeNardo GL. PMID: 14506182.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    127. Characterization of human IgG antimouse antibody in patients with B-cell malignancies. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):4013S-21S. DeNardo GL, Mirick GR, Kroger LA, Bradt BM, Lamborn KR, DeNardo SJ. PMID: 14506202.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    128. Gliomatosis cerebri: a review of 22 cases. Neurosurgery. 2003 Aug; 53(2):261-71; discussion 271. Vates GE, Chang S, Lamborn KR, Prados M, Berger MS. PMID: 12925240.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    129. Detection of hypoxia in human brain tumor xenografts using a modified comet assay. Neoplasia. 2003 Jul-Aug; 5(4):288-96. Wang J, Klem J, Wyrick JB, Ozawa T, Cunningham E, Golinveaux J, Allen MJ, Lamborn KR, Deen DF. PMID: 14511400; PMCID: PMC1502416.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    130. Radiation therapy for intracranial germ cell tumors. Int J Radiat Oncol Biol Phys. 2003 Jun 01; 56(2):511-8. Haas-Kogan DA, Missett BT, Wara WM, Donaldson SS, Lamborn KR, Prados MD, Fisher PG, Huhn SL, Fisch BM, Berger MS, Le QT. PMID: 12738328.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    131. Repeated operations for infiltrative low-grade gliomas without intervening therapy. J Neurosurg. 2003 Jun; 98(6):1165-9. Schmidt MH, Berger MS, Lamborn KR, Aldape K, McDermott MW, Prados MD, Chang SM. PMID: 12816258.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    132. Grade II astrocytomas are subgrouped by chromosome aberrations. Cancer Genet Cytogenet. 2003 Apr 01; 142(1):1-7. Hirose Y, Aldape KD, Chang S, Lamborn K, Berger MS, Feuerstein BG. PMID: 12660025.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    133. Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts. Blood. 2003 May 01; 101(9):3641-7. Tuscano JM, O'Donnell RT, Miers LA, Kroger LA, Kukis DL, Lamborn KR, Tedder TF, DeNardo GL. PMID: 12511412.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    134. Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma. Int J Radiat Oncol Biol Phys. 2002 Dec 01; 54(5):1397-404. Larson DA, Prados M, Lamborn KR, Smith V, Sneed PK, Chang S, Nicholas KM, Wara WM, Devriendt D, Kunwar S, Berger M, McDermott MW. PMID: 12459362.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    135. Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res. 2002 Nov 01; 62(21):6205-10. Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P, Passe S, Jenkins RB, Aldape KD. PMID: 12414648.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    136. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat Genet. 2002 Nov; 32(3):453-8. Zardo G, Tiirikainen MI, Hong C, Misra A, Feuerstein BG, Volik S, Collins CC, Lamborn KR, Bollen A, Pinkel D, Albertson DG, Costello JF. PMID: 12355068.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    137. Predictive model for pain recurrence after posterior fossa surgery for trigeminal neuralgia. Arch Neurol. 2002 Aug; 59(8):1297-302. Theodosopoulos PV, Marco E, Applebury C, Lamborn KR, Wilson CB. PMID: 12164727.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    138. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts. Cancer Res. 2002 Aug 01; 62(15):4263-72. Burke PA, DeNardo SJ, Miers LA, Lamborn KR, Matzku S, DeNardo GL. PMID: 12154028.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimals
    139. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol. 2002 Jul 15; 20(14):3081-7. Donaldson SS, Hudson MM, Lamborn KR, Link MP, Kun L, Billett AL, Marcus KC, Hurwitz CA, Young JA, Tarbell NJ, Weinstein HJ. PMID: 12118021.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    140. Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas. Neuro Oncol. 2002 07; 4(3):179-86. Kuriyama H, Lamborn KR, O'Fallon JR, Iturria N, Sebo T, Schaefer PL, Scheithauer BW, Buckner JC, Kuriyama N, Jenkins RB, Israel MA. PMID: 12084348; PMCID: PMC1920640.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    141. Delayed surgical resection reduces intraoperative blood loss for embolized meningiomas. Neurosurgery. 2002 Jun; 50(6):1231-5; discussion 1235-7. Chun JY, McDermott MW, Lamborn KR, Wilson CB, Higashida R, Berger MS. PMID: 12015840.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    142. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res. 2002 May; 8(5):1100-6. Ermoian RP, Furniss CS, Lamborn KR, Basila D, Berger MS, Gottschalk AR, Nicholas MK, Stokoe D, Haas-Kogan DA. PMID: 12006525.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    143. Growth of human glioblastomas as xenografts in the brains of athymic rats. In Vivo. 2002 Jan-Feb; 16(1):55-60. Ozawa T, Wang J, Hu LJ, Bollen AW, Lamborn KR, Deen DF. PMID: 11980362.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    144. Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6. Prostate. 2002 Jan 01; 50(1):27-37. O'Donnell RT, DeNardo SJ, Miers LA, Lamborn KR, Kukis DL, DeNardo GL, Meyers FJ. PMID: 11757033.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    145. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res. 2002 Jan; 8(1):180-7. Burton EC, Lamborn KR, Forsyth P, Scott J, O'Campo J, Uyehara-Lock J, Prados M, Berger M, Passe S, Uhm J, O'Neill BP, Jenkins RB, Aldape KD. PMID: 11801556.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    146. Dose conformity of gamma knife radiosurgery and risk factors for complications. Int J Radiat Oncol Biol Phys. 2001 Dec 01; 51(5):1313-9. Nakamura JL, Verhey LJ, Smith V, Petti PL, Lamborn KR, Larson DA, Wara WM, McDermott MW, Sneed PK. PMID: 11728692.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    147. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg. 2001 Nov; 95(5):735-45. Keles GE, Lamborn KR, Berger MS. PMID: 11702861.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    148. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. Cancer Res. 2001 Oct 15; 61(20):7683-8. Kunwar S, Mohapatra G, Bollen A, Lamborn KR, Prados M, Feuerstein BG. PMID: 11606412.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    149. A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia. 2001 May-Jun; 3(3):255-63. Ruan H, Su H, Hu L, Lamborn KR, Kan YW, Deen DF. PMID: 11494119; PMCID: PMC1505593.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    150. Relationship between pattern of enhancement and local control of brain metastases after radiosurgery. Int J Radiat Oncol Biol Phys. 2001 May 01; 50(1):139-46. Goodman KA, Sneed PK, McDermott MW, Shiau CY, Lamborn KR, Chang S, Park E, Wara WM, Larson DA. PMID: 11316557.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    151. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model. Cancer Res. 2001 Mar 01; 61(5):1805-9. Kuriyama N, Kuriyama H, Julin CM, Lamborn KR, Israel MA. PMID: 11280727.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    152. Radiosurgery for brain metastases from primary lung carcinoma. Cancer J. 2001 Mar-Apr; 7(2):121-31. Hoffman R, Sneed PK, McDermott MW, Chang S, Lamborn KR, Park E, Wara WM, Larson DA. PMID: 11324765.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    153. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res. 2001 Feb 01; 61(3):1122-8. Simmons ML, Lamborn KR, Takahashi M, Chen P, Israel MA, Berger MS, Godfrey T, Nigro J, Prados M, Chang S, Barker FG, Aldape K. PMID: 11221842.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    154. Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice. Prostate. 2000 Aug 01; 44(3):187-92. O'Donnell RT, DeNardo SJ, DeNardo GL, Miers L, Lamborn KR, Kukis DL, Meyers FJ. PMID: 10906734.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    155. Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy. Cancer Biother Radiopharm. 2000 Feb; 15(1):71-9. DeNardo SJ, Burke PA, Leigh BR, O'Donnell RT, Miers LA, Kroger LA, Goodman SL, Matzku S, Jonczyk A, Lamborn KR, DeNardo GL. PMID: 10740655.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    156. A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma. J Nucl Med. 1999 Dec; 40(12):2014-20. O'Donnell RT, DeNardo GL, Kukis DL, Lamborn KR, Shen S, Yuan A, Goldstein DS, Carr CE, Mirick GR, DeNardo SJ. PMID: 10616879.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    157. Long-term impairment of subependymal repopulation following damage by ionizing irradiation. Exp Neurol. 1999 Nov; 160(1):66-77. Tada E, Yang C, Gobbel GT, Lamborn KR, Fike JR. PMID: 10630191.
      View in: PubMed   Mentions: 35     Fields:    Translation:AnimalsCellsPHPublic Health
    158. Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX. Neoplasia. 1999 Nov; 1(5):431-7. Ruan H, Wang J, Hu L, Lin CS, Lamborn KR, Deen DF. PMID: 10933058; PMCID: PMC1508106.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    159. 67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3330s-3336s. O'Donnell RT, DeNardo GL, Kukis DL, Lamborn KR, Shen S, Yuan A, Goldstein DS, Mirick GR, DeNardo SJ. PMID: 10541382.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCTClinical Trials
    160. Radiopotentiation of human brain tumor cells by sodium phenylacetate. Cancer Lett. 1999 Aug 03; 142(2):139-46. Ozawa T, Lu RM, Hu LJ, Lamborn KR, Prados MD, Deen DF. PMID: 10463769.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    161. Critical Lym-1 binding residues on polymorphic HLA-DR molecules. Mol Immunol. 1999 Aug; 36(11-12):789-97. Rose LM, Deng CT, Scott SL, Xiong CY, Lamborn KR, Gumerlock PH, DeNardo GL, Meares CF. PMID: 10593517.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    162. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia. J Nucl Med. 1999 Aug; 40(8):1317-26. DeNardo GL, DeNardo SJ, Shen S, DeNardo DA, Mirick GR, Macey DJ, Lamborn KR. PMID: 10450684.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    163. Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer. 1999 Jul 15; 86(2):331-9. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G, Collins VP, Feuerstein BG. PMID: 10421270.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    164. Toxicology of a boronated porphyrin in dogs. Photochem Photobiol. 1999 May; 69(5):587-94. Tibbitts J, Fike JR, Lamborn KR, Bollen AW, Kahl SB. PMID: 10333766.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    165. Radiation-induced DNA double-strand breaks and rejoining in malignant glioma cells. Int J Radiat Biol. 1999 May; 75(5):563-70. Ozawa T, Wang J, Lamborn KR, Deen DF. PMID: 10374938.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    166. Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients. Cancer. 1999 Feb 15; 85(4):925-35. Lamborn KR, Prados MD, Kaplan SB, Davis RL. PMID: 10091772.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    167. Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results. Neurosurgery. 1999 Feb; 44(2):254-61; discussion 261-3. Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. PMID: 9932878.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    168. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys. 1999 Feb 01; 43(3):549-58. Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, Gutin PH, Phillips TL, Wara WM, Larson DA. PMID: 10078636.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    169. Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol. Anticancer Res. 1998 Nov-Dec; 18(6A):4011-8. Denardo SJ, Richman CM, Kukis DL, Shen S, Lamborn KR, Miers LA, Kroger LA, Perez EA, Denardo GL. PMID: 9891439.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    170. Tumor cell apoptosis present at diagnosis may predict treatment outcome for patients with medulloblastoma. J Pediatr Hematol Oncol. 1998 Nov-Dec; 20(6):520-7. Haslam RH, Lamborn KR, Becker LE, Israel MA. PMID: 9856671.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    171. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab. 1998 Oct; 83(10):3411-8. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. PMID: 9768640.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    172. Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma. J Clin Oncol. 1998 Oct; 16(10):3246-56. DeNardo GL, DeNardo SJ, Goldstein DS, Kroger LA, Lamborn KR, Levy NB, McGahan JP, Salako Q, Shen S, Lewis JP. PMID: 9779698.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    173. Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts. Clin Cancer Res. 1998 Oct; 4(10):2483-90. DeNardo GL, Kroger LA, Meares CF, Richman CM, Salako Q, Shen S, Lamborn KR, Peterson JJ, Miers LA, Zhong GR, DeNardo SJ. PMID: 9796981.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    174. Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody. Cancer Biother Radiopharm. 1998 Aug; 13(4):239-54. DeNardo GL, DeNardo SJ, Lamborn KR, Goldstein DS, Levy NB, Lewis JP, O'Grady LF, Raventos A, Kroger LA, Macey DJ, McGahan JP, Mills SL, Shen S. PMID: 10850360.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    175. Characterization of human glioblastoma xenograft growth in athymic mice. In Vivo. 1998 Jul-Aug; 12(4):369-74. Ozawa T, Wang J, Hu LJ, Lamborn KR, Bollen AW, Deen DF. PMID: 9706486.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    176. Cerebrovascular effects of the bradykinin analog RMP-7 in normal and irradiated dog brain. J Neurooncol. 1998 May; 37(3):199-215. Fike JR, Gobbel GT, Mesiwala AH, Shin HJ, Nakagawa M, Lamborn KR, Seilhan TM, Elliott PJ. PMID: 9524078.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsPHPublic Health
    177. Quantification of iodine-131 in tumors using a threshold based on image contrast. Eur J Nucl Med. 1998 May; 25(5):497-502. DeNardo GL, Shen S, DeNardo SJ, Liao SQ, Lamborn KR, DeNardo DA, Yuan A. PMID: 9575245.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    178. Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts. J Nucl Med. 1998 May; 39(5):842-9. DeNardo SJ, Kukis DL, Miers LA, Winthrop MD, Kroger LA, Salako Q, Shen S, Lamborn KR, Gumerlock PH, Meares CF, DeNardo GL. PMID: 9591587.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    179. Second cancers following pediatric Hodgkin's disease. J Clin Oncol. 1998 Feb; 16(2):536-44. Wolden SL, Lamborn KR, Cleary SF, Tate DJ, Donaldson SS. PMID: 9469338.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    180. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1998 Jan 15; 40(2):287-95. Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH. PMID: 9457811.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCTClinical Trials
    181. Radiation in pediatric Hodgkin's disease. J Clin Oncol. 1998 Jan; 16(1):391-3. Donaldson SS, Lamborn KR. PMID: 9440772.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    182. Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma. Cancer. 1997 Dec 15; 80(12 Suppl):2583-90. DeNardo SJ, Kroger LA, Lamborn KR, Miers LA, O'Donnell RT, Kukis DL, Richman CM, DeNardo GL. PMID: 9406713.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    183. Increased survival associated with radiolabeled Lym-1 therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Cancer. 1997 Dec 15; 80(12 Suppl):2706-11. DeNardo GL, Lamborn KR, Goldstein DS, Kroger LA, DeNardo SJ. PMID: 9406728.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    184. Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2. Cancer. 1997 Dec 15; 80(12 Suppl):2576-82. DeNardo GL, Kukis DL, DeNardo SJ, Shen S, Mausner LF, O'Donnell RT, Lamborn KR, Meyers FJ, Srivastava SC, Miers LA. PMID: 9406712.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    185. Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies. Clin Cancer Res. 1997 Aug; 3(8):1253-60. Lamborn KR, DeNardo GL, DeNardo SJ, Goldstein DS, Shen S, Larkin EC, Kroger LA. PMID: 9815807.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    186. Adult medulloblastoma: an analysis of survival and prognostic factors. Cancer J Sci Am. 1997 Jul-Aug; 3(4):238-45. Le QT, Weil MD, Wara WM, Lamborn KR, Prados MD, Edwards MS, Gutin PH. PMID: 9263630.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    187. Apoptosis in the subependyma of young adult rats after single and fractionated doses of X-rays. Cancer Res. 1997 Jul 01; 57(13):2694-702. Shinohara C, Gobbel GT, Lamborn KR, Tada E, Fike JR. PMID: 9205079.
      View in: PubMed   Mentions: 33     Fields:    Translation:Animals
    188. Effects of Matrigel on the SF-767 malignant glioma athymic mouse tumor model. Anticancer Res. 1997 Jul-Aug; 17(4A):2419-25. Wyrick BJ, Ozawa T, Lamborn KR, Bollen AW, Deen DF. PMID: 9252657.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    189. Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody. Anticancer Res. 1997 May-Jun; 17(3B):1745-51. Denardo SJ, O'Grady LF, Richman CM, Goldstein DS, O'Donnell RT, Denardo DA, Kroger LA, Lamborn KR, Hellström KE, Hellström I, Denardo GL. PMID: 9179228.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCTClinical Trials
    190. Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts. Proc Natl Acad Sci U S A. 1997 Apr 15; 94(8):4000-4. DeNardo SJ, Kukis DL, Kroger LA, O'Donnell RT, Lamborn KR, Miers LA, DeNardo DG, Meares CF, DeNardo GL. PMID: 9108094; PMCID: PMC20557.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    191. Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys. 1997 Jan 15; 37(2):375-83. Shiau CY, Sneed PK, Shu HK, Lamborn KR, McDermott MW, Chang S, Nowak P, Petti PL, Smith V, Verhey LJ, Ho M, Park E, Wara WM, Gutin PH, Larson DA. PMID: 9069310.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    192. Reproducibility of operator processing for radiation dosimetry. Nucl Med Biol. 1997 Jan; 24(1):77-83. Shen S, DeNardo GL, DeNardo SJ, Yuan A, DeNardo DA, Lamborn KR. PMID: 9080478.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    193. Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodies. J Nucl Med. 1996 Dec; 37(12):1970-5. DeNardo DA, DeNardo GL, Yuan A, Shen S, DeNardo SJ, Macey DJ, Lamborn KR, Mahe M, Groch MW, Erwin WD. PMID: 8970516.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    194. Factors influencing survival after gamma knife radiosurgery for patients with single and multiple brain metastases. Cancer J Sci Am. 1996 Nov-Dec; 2(6):335-42. Shu HK, Sneed PK, Shiau CY, McDermott MW, Lamborn KR, Park E, Ho M, Petti PL, Smith V, Verhey LJ, Wara WM, Gutin PH, Larson DA. PMID: 9166554.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    195. Microglial responses after focal radiation-induced injury are affected by alpha-difluoromethylornithine. Int J Radiat Oncol Biol Phys. 1996 Aug 01; 36(1):113-23. Nakagawa M, Bellinzona M, Seilhan TM, Gobbel GT, Lamborn KR, Fike JR. PMID: 8823266.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCellsPHPublic Health
    196. Long-term follow-up after high-activity 125I brachytherapy for pediatric brain tumors. Pediatr Neurosurg. 1996 Jun; 24(6):314-22. Sneed PK, Russo C, Scharfen CO, Prados MD, Malec MK, Larson DA, Lamborn KR, Lamb SA, Voss B, Weaver KA, Phillips TL, Gutin PH, Wara WM, Edwards MS. PMID: 8988497.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    197. Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1996 Apr 01; 35(1):37-44. Sneed PK, Lamborn KR, Larson DA, Prados MD, Malec MK, McDermott MW, Weaver KA, Phillips TL, Wara WM, Gutin PH. PMID: 8641924.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    198. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg. 1996 Mar; 84(3):442-8. Barker FG, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK, McDermott MW, Sneed PK, Wara WM, Wilson CB. PMID: 8609556.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    199. Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival. Int J Radiat Oncol Biol Phys. 1996 Mar 01; 34(4):803-8. Barker FG, Prados MD, Chang SM, Davis RL, Gutin PH, Lamborn KR, Larson DA, McDermott MW, Sneed PK, Wilson CB. PMID: 8598356.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    200. Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression. Cancer Res. 1995 Dec 01; 55(23 Suppl):5837s-5841s. DeNardo SJ, Gumerlock PH, Winthrop MD, Mack PC, Chi SG, Lamborn KR, Shen S, Miers LA, deVere White RW, DeNardo GL. PMID: 7493356.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    201. Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies. Cancer Res. 1995 Dec 01; 55(23 Suppl):5893s-5898s. DeNardo GL, Lamborn KR, DeNardo SJ, Goldstein DS, Dolber-Smith EG, Kroger LA, Larkin EC, Shen S. PMID: 7493366.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    202. Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery. 1995 May; 36(5):898-903; discussion 903-4. Sneed PK, Prados MD, McDermott MW, Larson DA, Malec MK, Lamborn KR, Davis RL, Weaver KA, Wara WM, Phillips TL, et al. PMID: 7791979.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    203. Analysis of antiglobulin (HAMA) response in a group of patients with B-lymphocytic malignancies treated with 131I-Lym-1. Int J Biol Markers. 1995 Apr-Jun; 10(2):67-74. De Nardo GL, Kroger LA, Mirick GR, Lamborn KR, De Nardo SJ. PMID: 7561241.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCellsPHPublic HealthCTClinical Trials
    204. The biologic window for chimeric L6 radioimmunotherapy. Cancer. 1994 Feb 01; 73(3 Suppl):1023-32. DeNardo SJ, Mirick GR, Kroger LA, O'Grady LF, Erickson KL, Yuan A, Lamborn KR, Hellstrom I, Hellstrom KE, DeNardo GL. PMID: 8306244.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    205. Use of response surface statistical designs to detect effects of biologic response modifiers such as IL-2. Biotechnol Ther. 1994; 5(1-2):15-26. DeNardo GL, Lamborn KR, DeNardo SJ, Kroger LA. PMID: 7703830.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    206. High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys. 1992; 24(4):583-91. Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, Weaver KA, Malec M, Acord P, Lamborn KR, et al. PMID: 1429079.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    207. Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy. Int J Rad Appl Instrum B. 1991; 18(6):621-31. DeNardo SJ, O'Grady LF, Macey DJ, Kroger LA, DeNardo GL, Lamborn KR, Levy NB, Mills SL, Hellstrom I, Hellstrom KE. PMID: 1743985.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    208. Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas. A phase II study of the Northern California Oncology Group. Invest New Drugs. 1990 Nov; 8(4):387-9. Carlson RW, Doroshow JH, Odujinrin OO, Flam MS, Malec M, Lamborn KR. PMID: 2150672.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    Kathleen's Networks
    Concepts (677)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (75)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.